The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2.
D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007376:Interleukin-2 / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use*
D007376:Interleukin-2; D011994:Recombinant Proteins